Our dedicated staff, valued partnerships, scientific leadership and good luck have brought us great success. To further that success, dermatology company Galderma is engaged in active outreach to the best scientific organizations worldwide.
Because we embrace the best ideas in science, building effective collaborations of all kinds – from early stage development to late stage licensing – is a priority for Galderma. The Company forms licensing partnerships around innovative product candidates and technologies. Galderma is most interested in opportunities that have a well-validated target, a novel mechanism of action, well-characterized pharmaceutical properties, a strong intellectual property position and preclinical or clinical data. Dermatology company Galderma’s technology licensing agreements must be science driven, provide access to technology that extends our existing programs and are consistent with our research strategies.